Thronson Susan 4

What Happened

• Susan Thronson, a director of Trulieve Cannabis Corp., was granted 23,438 restricted stock units (RSUs) on March 13, 2026. The award is reported as an acquisition at a $0 per-unit price (total $0) because RSUs represent contingent rights to future shares rather than an immediate cash purchase.

Key Details

• Transaction date and type: 2026-03-13 — Grant/Award (RSUs).
• Price reported: $0.00 per RSU (award/contingent grant).
• Shares received: 23,438 RSUs (each RSU represents a right to one subordinate voting share if vested).
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: RSUs vest on the earliest of (i) end of Thronson’s service on the board, (ii) a change of control, or (iii) December 1, 2032.
• Timeliness: Report filed 2026-03-17 (within the standard Form 4 filing window).

Context

• RSUs are a form of compensation/retention award that convert into actual shares only upon vesting; they do not represent immediate market sales or cash proceeds. This filing documents the grant itself and does not indicate that shares were sold or purchased on the open market.